Dr. Ellinor was raised in Cincinnati and graduated from the University of Cincinnati with a degree in Biology. He attended Stanford University for medical and graduate school. After completing doctoral work in the laboratory of Dr. Richard Tsien on the structure and function of calcium channels, he moved to Boston for medical residency at Brigham and Women’s Hospital. He then completed cardiology and cardiac electrophysiology fellowship training at Massachusetts General Hospital. Dr. Ellinor joined the staff of MGH in 2001, served as the Medical Director of the Cardiac Step-Down Unit for thirteen years, and became the Director of the Cardiac Arrhythmia Service in 2016. He is an Associate Professor at Harvard Medical School and an Associate Member at the Broad Institute.
Dr. Ellinor’s research work has focused on identifying the molecular basis of atrial fibrillation. Dr. Ellinor currently helps to lead the AFGen Consortium, an international group of investigators studying the genetics of atrial fibrillation. Dr. Ellinor also co-leads a unique academic industrial partnership between the Broad Institute and Bayer focused on identifying novel therapeutic targets for myocardial infarction and atrial fibrillation.
Patrick T. Ellinor is Director of the Cardiac Arrhythmia Service at Massachusetts General Hospital, an Associate Professor at Harvard Medical School and an Associate Member at the Broad Institute of Harvard and MIT. His research work focuses on the genetics of atrial fibrillation and he has received grant support from the NIH, AHA, and Fondation Leducq. Details of his research work and publications can be found at: www.ellinorlab.org.